Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in ...

Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this ...

Not so long ago, the question was: is a diesel- or petrol-powered car right for me ... These batteries come in either cell, ...

This success suggests that the complex interactions between therapeutic cells and their targets could lead to innovative treatments for both autoimmune diseases and cancer. Initial trials using CAR T ...

The agency reviewed data from the FELIX trial, in which 63 percent of patients achieved a complete remission on the cell therapy at any time point.

People living with the disease have been given hope of lifelong relief by a new cell therapy which has had successful results ...

As the new year is here, take a look at some of the most common New Year's resolutions, with tips on how to follow through ...

UC San Francisco treated its first brain cancer patient with an experimental new CAR-T therapy discovered and manufactured at ...

Multiple myeloma is the second most common hematologic malignancy, but there is a treatment gap for patients with disease ...